3,440 Shares in USANA Health Sciences, Inc. (NYSE:USNA) Purchased by Hikari Power Ltd

Hikari Power Ltd bought a new stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 3,440 shares of the company’s stock, valued at approximately $255,000.

A number of other hedge funds have also added to or reduced their stakes in USNA. Rhumbline Advisers lifted its position in USANA Health Sciences by 5.4% during the second quarter. Rhumbline Advisers now owns 12,910 shares of the company’s stock valued at $828,000 after purchasing an additional 664 shares during the last quarter. SG Americas Securities LLC bought a new position in USANA Health Sciences during the second quarter valued at $162,000. Bank of New York Mellon Corp lifted its position in USANA Health Sciences by 13.4% during the second quarter. Bank of New York Mellon Corp now owns 90,193 shares of the company’s stock valued at $5,782,000 after purchasing an additional 10,670 shares during the last quarter. Legal & General Group Plc lifted its position in USANA Health Sciences by 7.6% during the second quarter. Legal & General Group Plc now owns 4,040 shares of the company’s stock valued at $259,000 after purchasing an additional 284 shares during the last quarter. Finally, BNP Paribas Arbitrage SA lifted its position in USANA Health Sciences by 13.1% during the second quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock valued at $135,000 after purchasing an additional 245 shares during the last quarter. Institutional investors and hedge funds own 43.82% of the company’s stock.

Shares of USANA Health Sciences, Inc. (NYSE USNA) opened at $74.40 on Friday. USANA Health Sciences, Inc. has a twelve month low of $52.55 and a twelve month high of $76.15. The firm has a market cap of $1,805.44, a PE ratio of 20.50 and a beta of 1.06.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.02 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.11. USANA Health Sciences had a net margin of 8.79% and a return on equity of 26.38%. The company had revenue of $261.77 million during the quarter, compared to analyst estimates of $259.52 million. During the same quarter last year, the business posted $2.40 EPS. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. equities analysts expect that USANA Health Sciences, Inc. will post 3.7 earnings per share for the current year.

Several equities research analysts have recently issued reports on the stock. BidaskClub upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a report on Thursday, October 26th. Pivotal Research raised their target price on shares of USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, October 25th.

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 1,710 shares of the firm’s stock in a transaction dated Thursday, October 26th. The shares were sold at an average price of $67.01, for a total transaction of $114,587.10. Following the transaction, the director now owns 1,710 shares of the company’s stock, valued at approximately $114,587.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Global Ltd Gull sold 93,443 shares of the firm’s stock in a transaction dated Monday, October 30th. The shares were sold at an average price of $67.08, for a total transaction of $6,268,156.44. Following the transaction, the insider now directly owns 12,089,267 shares in the company, valued at approximately $810,948,030.36. The disclosure for this sale can be found here. Insiders have sold a total of 623,752 shares of company stock valued at $41,411,372 in the last quarter. 53.20% of the stock is currently owned by company insiders.

WARNING: “3,440 Shares in USANA Health Sciences, Inc. (NYSE:USNA) Purchased by Hikari Power Ltd” was reported by TrueBlueTribune and is owned by of TrueBlueTribune. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at https://www.truebluetribune.com/2018/01/19/3440-shares-in-usana-health-sciences-inc-usna-purchased-by-hikari-power-ltd.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply